for me to know for others to guess
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Discount'emDixon T/A Verifies you are responsible for the pps decline
Authorized Shares 4,500,000,000 09/22/2023
Outstanding Shares 3,450,665,355 09/22/2023 >85,907,019
Restricted 1,198,207,118 09/22/2023 >61,757,394
Unrestricted 2,252,458,237 09/22/2023 >24,149,625
Held at DTC 2,177,860,785 09/22/2023
YTD/DTC 619,535,874
619,535,874 divided by 9(months) = 68,837,319 discounted shares monthly
Authorized Shares 4,500,000,000 09/15/2023
Outstanding Shares 3,364,758,336 09/15/2023
Restricted 1,136,449,724 09/15/2023
Unrestricted 2,228,308,612 09/15/2023
Held at DTC 2,177,860,785 09/15/2023
Discount'emDixon Authorized Shares 4,500,000,000 09/08/2023
Outstanding Shares 3,364,758,336 09/08/2023 >40,175,569
Restricted 1,136,449,724 09/08/2023 >20,000,000
Unrestricted 2,228,308,612 09/08/2023 >20,175,569
Held at DTC 2,177,860,785 09/08/2023 >20,175,569 in 10 days
YTD/DTC 619,535,874
619,535,874 divided by 9(months) = 68,837,319 discounted shares monthly
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172863077&txt2find=Outstanding
Dixon as the CEO you are also responsible for the corporate failures & both you/Ichim are responsible for the Ongoing ________(s)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172859176&txt2find=yay
https://cdernextgenportal.fda.gov/Login_CDER?ec=302&startURL=%2Fs%2F
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/
Again FDA will reply Yay or Nay (as the 90 day time limit for for either response is set by the FDA) so what does TSOI have to say as they owe shareholders for once just the simple truth. If nay, why? what was/will be the company's response to both the FDA, shareholders & their path forward.
this now is a Material Event as defined by the SEC after a Public Release announcing said Fact
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172859176
9/24 will be 90 days after the filing accessdata.fda.gov/scripts/...
Search Orphan Drug Designations and Approvals
https://www.accessdata.fda.go
https://www.virtu.com/market-making/ Notice only on the Ask currently
Arrived 09.22/2023 @ 10:59:59
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172855713
after running away…VPN another…#TheKingsmen #BadlyBent got scared
by TimGDixon » Wed Sep 21, 2022 4:51 am
Codycrusher wrote: ?Wed Sep 21, 2022 4:33 am
I’m curious on the status of general ARDS, that is a big move and it’s very important for phase 3 because you always said the endgame here is to go for general ARDS in phase 3 and for commercialization, so I know how important that is for these trials and all.
I’m excited to see you get the approval and the announcement, I assume it should be any day now because you filed last month and made the PR on the 25th and they have to respond within 30 days I believe so that leaves the end of this month as the timeline and I’m very excited for that.
We have not heard back from FDA yet on amendment but that is just part of the process. Oh I know people want to dig up regulations and then fixate on some number of days the reg's speak of but do what I do and you will see that those things are just ink on paper because they can stop and restart the clock as needed so we just wait patiently. Here's what you need to know and everything in between is called patience/ the minute FDA signed off on our form 1571 that converted the academic phase 2 to a commercial phase 3, the trial began and the trial will continue until we have a BLA with FDA for use in the general population with diagnosed ARDS. Thats it in a nutshell. So everyone needs to come to grips with that. There isn't much else that will come out before BLA other than our published results in peer reviewed journal which will set us up for BLA application. Thats it.
We have a clinical trial to conduct in CTE and Breast Cancer and COPD and no one even talks about that - we just filed a new patent to license to Campbell (note to self, draft license and send to Kalina). Were about to launch the first of several new spin-offs to accommodate those IND's and working on many new patents yet to be filed.
I hope you all can find excitement in other things while we do our things behind the scenes...
https://forum.therapeuticsolutionsint.com/viewtopic.php?t=384&start=15
Schooling idiots like @Webster2000, his multiple aliases, Corporate fools & CONsultants is just 2 damn EZ hence why the idiots never try to refute the irrefutable FACTS
try harder Lil Idaho Boi's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172871202
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172871200
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172871500
Howling as once disturbed Wolf awakes
Dixon contradicting himself & being schooled as well
Re: Outstanding shares
Post by TimGDixon » Tue Dec 06, 2022 3:54 pm
noslippas808 wrote: ?Tue Dec 06, 2022 3:50 pm
noslippas808 wrote: ?Tue Dec 06, 2022 3:50 pm
TimGDixon wrote: ?Tue Dec 06, 2022 3:43 pm
Nothing happened other than an increase in shares to 4.5bn. No coconuts, no go.
ok wait he have a 4 billion float now? what are all those shares being used for ?
and how did everyone on ST know this drop was dew to dilution?
no dilution. these are treasury shares for s1 reserves required in our upcoming amended filing. routine biz kaikaina
Frankly speaking ControllabilityIam @Webster2000 as I own you & all your aliases. Thanks for confirming
Subject to the provisions of the Freedom of Information Act, the SEC cannot disclose the existence or non-existence of an investigation or any information gathered unless made a matter of public record in proceedings brought before the SEC or in the courts.Sep 20, 2017
Does the SEC announce investigations?
The SEC's litigation is generally public, and the agency will typically issue a press release announcing its action. The press release will include a summary of the allegations and the relief being sought by the SEC.May 10, 2023
Are SEC investigations public?
By law, SEC investigations are confidential and non-public. Generally, the SEC Staff will provide information and materials to SEC whistleblowers on a need to know basis only.
Do companies have to disclose SEC investigations?
In a recent decision from the U.S. District Court for the Southern District of New York, Judge John G. Koeltl held that issuers do not have a general duty to disclose the existence of an SEC investigation or a Wells Notice.
What happens when you file a complaint with the SEC?
Process for Handling Complaints
OIEA may refer an investor complaint to other Offices or Divisions within the SEC, including the Division of Enforcement. The Division of Enforcement generally conducts investigations on a confidential basis.Apr 19, 2017
Don’t feel bad as I have said previously I own your sorry arse @Webster2000 all your aliases & all have seen the verified proof of said. Try harder lil Boi
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172856099
SS for comparison then to now w/ the in between prior2 @ the bottom
Authorized Shares 3,500,000,000 6/1/20
Outstanding Shares 1,879,692,516 6/16/20
Restricted 1,352,226,123 6/12/20
Unrestricted 517,466,393 6/12/20
Held at DTC 484,713,398 6/15/20
Authorized Shares 4,500,000,000 09/15/2023
Outstanding Shares 3,364,758,336 09/15/2023
Restricted 1,136,449,724 09/15/2023
Unrestricted 2,228,308,612 09/15/2023
Held at DTC 2,177,860,785 09/15/2023
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
Just the Facts TSOI SECURITY DETAILS Share Structure 12/17-03/04/21
Market Cap Market Cap 51,734,134 12/17/2021
Authorized Shares 3,500,000,000 12/17/2021
Outstanding Shares 2,311,123,860 12/17/2021 >16,927,248
Restricted 1,014,553,256 12/17/2021 >10,000,000
Unrestricted 1,296,570,604 12/17/2021 >6,927,248
Held at DTC 1,252,872,777 12/17/2021 >7,927,248
TSOI 11/15/21 Authorized Shares 3,500,000,000 1/15/2021
Outstanding Shares 2,294,196,612 11/15/2021
Restricted 1,004,553,256 11/15/2021
Unrestricted 1,289,643,356 11/15/2021
Held at DTC 1,244,945,529 11/15/2021
Share Structure Update 10/18/21
Market Cap Market Cap 87,926,139 10/21/2021
Authorized Shares 3,500,000,000 10/18/2021
Outstanding Shares 2,274,932,452 10/18/2021
Restricted 990,553,256 10/18/2021
Unrestricted 1,284,379,196 10/18/2021
Held at DTC 1,240,681,369 10/18/2021
O/S NO change
Restricted NO change
Unrestricted NO change
Held @ DTC >5m
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166066740
Authorized Shares 3,500,000,000 09/23/21
Updated O/S 2,274,135,577 09/23/21
Restricted 989,756,381 09/23/21
Unrestricted 1,284,379,196 09/23/21
Held at DTC 1,235,681,369 09/23/21
https://www.otcmarkets.com/stock/TSOI/security
as of 09/08/2021 $TSOI SECURITY DETAILS Share Structure
Market Cap Market Cap 177,382,575 09/15/2021
Authorized Shares3,500,000,000 09/08/2021
Outstanding Shares 2,274,135,577 09/08/2021
Restricted 1,094,756,381 09/08/2021
Unrestricted 1,179,379,196 09/08/2021
Held at DTC 1,129,681,369 09/08/2021
Share Structure 8/25/21
Market Cap Market Cap 201,463,566 08/31/2021
Authorized Shares 3,500,000,000 08/25/2021
Outstanding Shares 2,273,135,577 08/25/2021
Restricted 1,100,756,381 08/25/2021
Unrestricted 1,172,379,196 08/25/2021
Held at DTC 1,129,681,369 08/25/2021
TSOI Updated SS 9/01/21 http://investorshub.advfn.com/uimage/uploads/2021/9/1/jofddScreenshot_2021-09-01_174143.png
TSOI Share Structure
Market Cap Market Cap 138,081,770 08/11/2021
Authorized Shares 3,500,000,000 08/03/2021
Outstanding Shares 2,263,635,577 08/03/2021
Restricted 1,093,801,208 08/03/2021
Unrestricted 1,169,834,369 08/03/2021
Held at DTC 1,129,681,369 08/03/2021
TSOI Share Structure
Market Cap Market Cap 77,985,701 07/27/2021
Authorized Shares 3,500,000,000 7/09/2021
Outstanding Shares 2,259,800,077 07/09/2021
Restricted 1,092,501,208 07/09/2021
Unrestricted 1,167,298,869 07/09/2021
Held at DTC 1,119,045,869 07/09/2021
Float 303,593,877 08/16/20
7/9/21 TSOI SECURITY DETAILS
Share Structure
Market Cap 74,563,501 07/08/2021
Authorized Shares 3,500,000,000 06/02/2021
Outstanding Shares 2,252,673,740 06/02/2021
Restricted 1,088,601,692 06/02/2021
Unrestricted 1,164,072,048 06/02/2021
Held at DTC 1,092,456,980 06/02/2021
Float 303,593,877 08/16/2019
Par Value 0.001
TSOI SECURITY DETAILS 5/19/21
Share Structure
Market Cap Market Cap 116,553,339 05/25/2021
Authorized Shares 3,500,000,000 05/19/2021
Outstanding Shares 2,252,673,740 05/19/2021
Restricted 1,107,101,692 05/19/2021
Unrestricted 1,145,572,048 05/19/2021
Held at DTC 1,075,956,980 05/19/2021
Float 303,593,877 08/16/2019
TSOI SECURITY DETAILS
Share Structure
Market Cap 148,566,113 05/10/2021
Authorized Shares 3,500,000,000 05/04/2021
Outstanding Shares 2,251,001,716 05/04/2021
Restricted 1,107,101,692 05/04/2021
Unrestricted 1,143,900,024 n05/04/2021
Held at DTC 1,050,534,956 05/04/2021
Float 303,593,877 08/16/2019
Share Structure
Market Cap Market Cap 173,270,990 03/12/2021
Authorized Shares 3,500,000,000 03/04/2021
Outstanding Shares 2,243,571,019 03/04/2021
Restricted 1,279,963,335 03/04/2021
Unrestricted 963,607,684 03/04/2021
Held at DTC 805,734,684 03/04/2021
TSOI.... Authorized Sharesn 3,500,000,000
Outstanding Shares 2,243,571,019 03/04/2021
Restricted 1,279,963,335 03/04/2021
Unrestricted 963,607,684 03/04/2021
Held at DTC 805,734,684 03/04/2021
Float 303,593,877 03/04/202
Unrestricted 1,296,570,604 12/17/2021 >6,927,248
Held at DTC 1,252,872,777 12/17/2021 >7,927,248
TSOI 11/15/21 Authorized Shares 3,500,000,000 1/15/2021
Outstanding Shares 2,294,196,612 11/15/2021
Restricted 1,004,553,256 11/15/2021
Unrestricted 1,289,643,356 11/15/2021
Held at DTC 1,244,945,529 11/15/2021
Share Structure Update 10/18/21
Market Cap Market Cap 87,926,139 10/21/2021
Authorized Shares 3,500,000,000 10/18/2021
Outstanding Shares 2,274,932,452 10/18/2021
Restricted 990,553,256 10/18/2021
Unrestricted 1,284,379,196 10/18/2021
Held at DTC 1,240,681,369 10/18/2021
O/S NO change
Restricted NO change
Unrestricted NO change
Held @ DTC >5m
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166066740
Authorized Shares 3,500,000,000 09/23/21
Updated O/S 2,274,135,577 09/23/21
Restricted 989,756,381 09/23/21
Unrestricted 1,284,379,196 09/23/21
Held at DTC 1,235,681,369 09/23/21
https://www.otcmarkets.com/stock/TSOI/security
as of 09/08/2021 $TSOI SECURITY DETAILS Share Structure
Market Cap Market Cap 177,382,575 09/15/2021
Authorized Shares3,500,000,000 09/08/2021
Outstanding Shares 2,274,135,577 09/08/2021
Restricted 1,094,756,381 09/08/2021
Unrestricted 1,179,379,196 09/08/2021
Held at DTC 1,129,681,369 09/08/2021
Share Structure 8/25/21
Market Cap Market Cap 201,463,566 08/31/2021
Authorized Shares 3,500,000,000 08/25/2021
Outstanding Shares 2,273,135,577 08/25/2021
Restricted 1,100,756,381 08/25/2021
Unrestricted 1,172,379,196 08/25/2021
Held at DTC 1,129,681,369 08/25/2021
TSOI Updated SS 9/01/21 http://investorshub.advfn.com/uimage/uploads/2021/9/1/jofddScreenshot_2021-09-01_174143.png
TSOI Share Structure
Market Cap Market Cap 138,081,770 08/11/2021
Authorized Shares 3,500,000,000 08/03/2021
Outstanding Shares 2,263,635,577 08/03/2021
Restricted 1,093,801,208 08/03/2021
Unrestricted 1,169,834,369 08/03/2021
Held at DTC 1,129,681,369 08/03/2021
TSOI Share Structure
Market Cap Market Cap 77,985,701 07/27/2021
Authorized Shares 3,500,000,000 7/09/2021
Outstanding Shares 2,259,800,077 07/09/2021
Restricted 1,092,501,208 07/09/2021
Unrestricted 1,167,298,869 07/09/2021
Held at DTC 1,119,045,869 07/09/2021
Float 303,593,877 08/16/20
7/9/21 TSOI SECURITY DETAILS
Share Structure
Market Cap 74,563,501 07/08/2021
Authorized Shares 3,500,000,000 06/02/2021
Outstanding Shares 2,252,673,740 06/02/2021
Restricted 1,088,601,692 06/02/2021
Unrestricted 1,164,072,048 06/02/2021
Held at DTC 1,092,456,980 06/02/2021
Float 303,593,877 08/16/2019
Par Value 0.001
TSOI SECURITY DETAILS 5/19/21
Share Structure
Market Cap Market Cap 116,553,339 05/25/2021
Authorized Shares 3,500,000,000 05/19/2021
Outstanding Shares 2,252,673,740 05/19/2021
Restricted 1,107,101,692 05/19/2021
Unrestricted 1,145,572,048 05/19/2021
Held at DTC 1,075,956,980 05/19/2021
Float 303,593,877 08/16/2019
TSOI SECURITY DETAILS
Share Structure
Market Cap 148,566,113 05/10/2021
Authorized Shares 3,500,000,000 05/04/2021
Outstanding Shares 2,251,001,716 05/04/2021
Restricted 1,107,101,692 05/04/2021
Unrestricted 1,143,900,024 n05/04/2021
Held at DTC 1,050,534,956 05/04/2021
Float 303,593,877 08/16/2019
Share Structure
Market Cap Market Cap 173,270,990 03/12/2021
Authorized Shares 3,500,000,000 03/04/2021
Outstanding Shares 2,243,571,019 03/04/2021
Restricted 1,279,963,335 03/04/2021
Unrestricted 963,607,684 03/04/2021
Held at DTC 805,734,684 03/04/2021
TSOI.... Authorized Sharesn 3,500,000,000
Outstanding Shares 2,243,571,019 03/04/2021
Restricted 1,279,963,335 03/04/2021
Unrestricted 963,607,684 03/04/2021
Held at DTC 805,734,684 03/04/2021
Float 303,593,877 03/04/2021
Accumulated deficit (18,812,339 )
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Date: August 21, 2023
By: /s/ Timothy G. Dixon
Timothy G. Dixon
President and Chief Executive Officer
(Principal Executive Officer)
Do Disclaimers cover companies from fraudulent public releases
Disclaimers and disclosures must be clear and conspicuous. That is, consumers must be able to notice, read or hear, and understand the information. Still, a disclaimer or disclosure alone usually is not enough to remedy a false or deceptive claim.Dec 12, 2000
Avoidance of Disclaimer by Action for Fraudulent Misrepresentation
Do disclaimers hold up in court?
In conclusion, email disclaimers may not provide the legal protection that many people assume they do. While they can notify recipients and establish a duty of nondisclosure, they are unlikely to hold up in court as a binding contract. Furthermore, the majority of recipients don't even read them.Mar 28, 2023
Are Disclaimers Legally Binding? - TermsFeed
By themselves, Disclaimers serve as a warning to users. They give users realistic expectations for a product or service. However, that is often not enough to guarantee legal protection
so the crew never reads the disclaimers in the PRs
What is materiality in the SEC rules?
Materiality Definition Seen as Tough Task in New SEC Cyber ...
That is, information is material if a reasonable person would consider it important when making an investment decision, or if it would significantly affect existing publicly available information about a company. Any doubts should be resolved in the favor of the investor. Aug 2, 2023
If not https://www.businesswire.com/news/home/20230626834673/en/ June 26, 2023 09:00 AM Eastern Daylight Time TSOI/Dixon are required to file a 8k or @ the very least a detailed PR as whether approved or rejected as it is considered a Material event.by the SEC after a public release. 90 days yay or nay as that time limit is set by FDA
A 2nd one https://www.businesswire.com/news/home/20230712101628/en/
July 12, 2023 09:00 AM Eastern Daylight Time
Retsehc
Sep 18, 2023 11:44 AM
$TSOI Hi @thomasichim!
Should we expect to see JadiCell for ARDS listed in this database by Sunday? 9/24 will be 90 days after the filing accessdata.fda.gov/scripts/...
Search Orphan Drug Designations and Approvals
https://www.accessdata.fda.go
ThomasIchim
Sep 18, 2023 12:18 PM
@Retsehc @thomasichim $tsoi if it gets approved, yes
Codycrusher
Sep 18, 2023 1:17 PM
@Retsehc @thomasichim I’m praying for the approval too, I am curious what would happen if general ARDS doesn’t get approved by Sunday? Would that mean TSOI wouldn’t have a phase 3 general ARDS anymore or would they have more hoops to go through and restart the 90 day cycle in order to get it approved and the trials underway, many people including myself are excited to see general ARDS trials get underway hopefully sooner than later and toward BLA, it’s a important thing.
Bullish
time to rock or to roll & continue w/
But don’t feel bad as I take just a bit of pity on those lacking any real intellect @webster2000
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
ControllabilityIam as I own all 3 of your worthless aliases @webster2000
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
No one here can factually say that was a falsehood, only Dixon & he’s MIA or as some call it in hiding. Now these irrefutable Verified Facts are falsehoods (to be kind, very)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
https://stocktwits.com/ThomasIchim Nice try @Webster2000 @ deflection. My link contains all Ichi’s words Lil weak weather front all wind no substance as well. Much like Sybil
TSOI today…wonder the last time we were @ a weak ass 0017/ pps
https://stocktwits.com/ThomasIchim some excerpts below, read them all
ThomasIchim
Sep 18, 2023 10:41 AM
@BunMac @TradersTrader $TSOi after what I heard this weekend I will defend my work and myself against these baseless accusations.
Significant damage to my reputation and income has occurred directly because of these monsters and now I have no option but to put my foot down.
ThomasIchim Yesterday 12:14 PM
@dannymac65 $tsoi
I will not sit here and watch you and your fellow paid bashers talk nonsense and lies.
I learned certain things this weekend that have really made me change my approach to you and your kind.
@ThomasIchim Yesterday 12:20 PM
@rosiebelle $TSOI @CEOTimDixonisaFRAUD
my sister is Gloria Ichim https://ichimlaw.com/
unlike you, we have nothing to hide
Wonder if his sister has any more knowledge than his supposed SEC attorney
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172845245
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172602771&txt2find=Why
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172393351&txt2find=start
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171988941&txt2find=start
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171921540&txt2find=start
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171912633&txt2find=start
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
7 days later SS Updated w/ no increases for the week
Authorized Shares 4,500,000,000 09/15/2023
Outstanding Shares 3,364,758,336 09/15/2023
Restricted 1,136,449,724 09/15/2023
Unrestricted 2,228,308,612 09/15/2023
Held at DTC 2,177,860,785 09/15/2023
Discount'emDixon Authorized Shares 4,500,000,000 09/08/2023
Outstanding Shares 3,364,758,336 09/08/2023 >40,175,569
Restricted 1,136,449,724 09/08/2023 >20,000,000
Unrestricted 2,228,308,612 09/08/2023 >20,175,569
Held at DTC 2,177,860,785 09/08/2023 >20,175,569 in 10 days
YTD/DTC 619,535,874
619,535,874 divided by 9(months) = 68,837,319 discounted shares monthly
Subject to the provisions of the Freedom of Information Act, the SEC cannot disclose the existence or non-existence of an investigation or any information gathered unless made a matter of public record in proceedings brought before the SEC or in the courts.Sep 20, 2017
Does the SEC announce investigations?
The SEC's litigation is generally public, and the agency will typically issue a press release announcing its action. The press release will include a summary of the allegations and the relief being sought by the SEC.May 10, 2023
Are SEC investigations public?
By law, SEC investigations are confidential and non-public. Generally, the SEC Staff will provide information and materials to SEC whistleblowers on a need to know basis only.
Do companies have to disclose SEC investigations?
In a recent decision from the U.S. District Court for the Southern District of New York, Judge John G. Koeltl held that issuers do not have a general duty to disclose the existence of an SEC investigation or a Wells Notice.
What happens when you file a complaint with the SEC?
Process for Handling Complaints
OIEA may refer an investor complaint to other Offices or Divisions within the SEC, including the Division of Enforcement. The Division of Enforcement generally conducts investigations on a confidential basis.Apr 19, 2017
2 Dividend 8Ks for comparison 09/13.2023 https://www.otcmarkets.com/filing/html?id=16927828&guid=nVg-k6UIqQyeJth
03/27/2023 https://www.otcmarkets.com/filing/html?id=16514967&guid=nVg-k6UIqQyeJth
5 1/2 months between the 2 filings
TradersTrader
Yesterday 10:21 PM
$TSOI pure speculation on my part, but I believe Campbell Neurosciences, given its depth of licensed intellectual property, will open between $5-$10/share on the NASDAQ.
How did I come to this valuation?
The science. It’s magnificent. And its novel, safe and effective.
CampbellScore/Diagnostic for suicidal ideation?
CampbellCell? Who is paying attention? Hope so…
Notwithstanding, CNSI’s team is a highly talented and dedicated group.
As TSOI looks on, they should be VERY proud of the work. CNSI is doing.
Let’s see what happens. 💪😎💪
campbellneurosciences.com/
sec.gov/ix?doc=/Archives/ed...
How are dividends deposited?
The most common type of dividend. Companies generally pay these in cash directly into the shareholder's brokerage account. Stock dividends. Instead of paying cash, companies can also pay investors with additional shares of stock.Jun 27, 2023
What must a shareholder do to compel distribution of a dividend?
A shareholder can obtain an injunction compelling payment of a reasonable dividend where the corporation is withholding dividends in bad faith for a fraudulent or abusive purpose. Once a dividend has been declared by the corporation, it is a debt of the corporation, and shareholders may bring suit to compel payment.
A spinoff is created when a company forms some part of its operations into a separate entity and distributes shares in it tax free to shareholders of the parent company. The number of shares that a parent company shareholder receives is based on the number they own in the parent company.
When a spinoff's shares start trading on a stock exchange, the value of the parent company's stock may drop by the value of the new company's stock. This is due to the fact that the parent company stock no longer reflects the value of the unit that was spun off. Parent company shareholders shouldn't be concerned by this price change because they own the spinoff's shares as well.
What happens to shareholders in a spinoff?
A corporation creates a spinoff by distributing 100% of its ownership interest in that business unit as shares of stock to existing shareholders. It can also offer its existing shareholders a discount to exchange their shares in the parent company for shares of the spinoff.
RESOLVED FURTHER, that an amended 8-K shall be filed once FINRA is satisfied all documents and information are verified regarding the public disclosure of the dividend distribution to be posted on OTC Markets;
FORM 8-K CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 12, 2023
Item 8.01 Other Events – Letter to Shareholders and Interested Parties.
To All Shareholders and Interested Parties:
In order to correct the record regarding Therapeutic Solutions International, Inc. (“TSOI” and/or the “Company”) and Campbell Neurosciences, Inc. (“CNSI”) relevant to their interests regarding the corporate action filed with FINRA to verify documentation and information and its associated 8-K filed 3/24/2023, the following resolutions based on shareholder consents and approvals of the boards of both TSOI and CSNI were adopted:
RESOLVED, that the Board of TSOI, with the approval and agreement of the Board of CNSI, believes that the dividend to TSOI shareholders of CNSI stock is in the best interest of the Company and relevant shareholders, the Board, therefore, pursuant to Nevada Revised Statutes Section NRS 78.215, and unanimously approved by TSOI Series A Preferred Stock holders representing at least 51% of the voting stock of TSOI, copies of which are appended hereto, authorizes and approves TSOI, who currently owns 15,660,000 (52%) of the shares of Campbell Neurosciences, Inc. (“CNSI”) common stock, pursuant to a called special meeting, discussed and unanimously approved the filing of the 8-K to address and correct any confusion that appears to have been created by prior PR, 8-Ks, and public information regarding Sandbox Dental Labs, Inc., (“Sandbox DL”), a Delaware corporation, namely the changing of its name to Campbell Neurosciences, Inc., which was not completed and public notice should likely have been done at that time, and the licensing of certain patents and related transactions in order to begin the process of spinning off the subsidiary from TSOI, the dividend distribution being part of said process, which have been rescinded in order to capitalize CNSI, as filed and certified in Delaware on 2/1/2021;
RESOLVED FURTHER, it is advisable to correct the record regarding CNSI the board of directors of the Company, with approval and consent of the board of CNSI, has determined that the 8-K, in correcting the above-described misapprehension and publicly state the intent to dissolve Sandbox DL and have authorized and begun steps to be taken in that regard, including filing of final tax returns with Delaware and the authority to file the Certification of Dissolution once proof of final tax returns are acquired;
RESOLVED FURTHER, relevant to the same validation process and FINRA responses re the dividend distribution corporate action, the 8-K shall also disclose a change in the ratio resulting from a disclosed issuance that was eligible to be included in the Dividend Offer on the deadline, to affirm the desired issuance of a dividend consisting of 10,000,000 shares of TSOI holdings in CNSI to TSOI shareholders ratio is now 1 to 0.00358 of TSOI common to CNSI common, respectively, the dividend distribution is conditional based upon an election to accept by the TSOI shareholder owning stock as of 4/7/2023, beneficial ownership of stock date of April 7, 2023 (“Dividend Offer”) remains the same, as well as Dividend Offer Date of April 8, 2023 and a closing date of July 10, 2023 (“The Dividend Offer will remain open for Ninety (90) days from the Dividend Offer Date”).
In addition, a correction of the percentage of shares that TSOI currently owns of CNSI, which has been stated with different results, including the 8-K of 3/24/2023, to clear up any shareholder, public or regulator confusion, that the actual percentage of ownership being 52% (15,660,000/30,045,000 shares issued = .5212), as stated above.
RESOLVED FURTHER, that an amended 8-K shall be filed once FINRA is satisfied all documents and information are verified regarding the public disclosure of the dividend distribution to be posted on OTC Markets;
RESOLVED FURTHER, that the officers of the Company are hereby authorized to do and perform any and all such acts, including execution and issuance of any and all documents, as said officers shall deem necessary or advisable, to carry out the purposes of the foregoing resolution. A facsimile copy of this resolution shall have the same legal effect as an original of the same.
Item 9.01 Financial Statements and Exhibits.
Exhibit Index
(99.1) Minutes and Resolutions of the Board of Directors of Therapeutic Solutions International, Inc.
(99.2) Minutes and Resolutions of the Board of Directors of Campbell Neurosciences, Inc.
(99.3) Purchase Agreement between TSOI and CNSI
(99.4) Exclusive Patent License Agreement between TSOI and CNSI 17-030416
(99.5) Exclusive Patent License Agreement between TSOI and CNSI 63-057315
(99.6) Exclusive Patent License Agreement between TSOI and CNSI 63-061202
(99.7) Exclusive Patent License Agreement between TSOI and CNSI 63-068388
(99.8) Exclusive Patent License Agreement between TSOI and CNSI 63-071381
(99.9) Exclusive Patent License Agreement between TSOI and CNSI 63-077723
(99.10) Exclusive Patent License Agreement between TSOI and CNSI 63-105964
(99.11) Exclusive Patent License Agreement between TSOI and CNSI 63-122862
(99.12) Exclusive Patent License Agreement between TSOI and CNSI 63-128759
(99.13) Exclusive Patent License Agreement between TSOI and CNSI 63-174291
(99.14) Exclusive Patent License Agreement between TSOI and CNSI 63-189630
104 Cover Page Interactive Data File (Embedded within the Inline XBRL document)
Discount'emDixon Authorized Shares 4,500,000,000 09/08/2023
Outstanding Shares 3,364,758,336 09/08/2023 >40,175,569
Restricted 1,136,449,724 09/08/2023 >20,000,000
Unrestricted 2,228,308,612 09/08/2023 >20,175,569
Held at DTC 2,177,860,785 09/08/2023 >20,175,569 in 10 days
YTD/DTC 619,535,874
619,535,874 divided by 9(months) = 68,837,319 discounted shares monthly
Current conversion pps = 0.00096 0.0012 x 20%= 0.00024 / 0.0012-0.00024 =0.00096
Now w/ the only Ongoing involving TSOI being years of falsehoods publicly relayed there is NO way in hell(o) the market would have any interest in absorbing 68,837,319 discounted shares monthly after viewing corporate meltdowns, Dixon's use of shareholder $ to purchase his dream Idaho property that he could NOT afford in his 40 previous years until the Ongoing clinical & EUA ______(s) as we now await for a continuation of the aforementioned.
Sadly these are irrefutable Facts
Authorized Shares 4,500,000,000 08/29/2023
Outstanding Shares 3,324,582,767 08/29/2023
Restricted 1,116,449,724 08/29/2023
Unrestricted 2,208,133,043 08/29/2023 >14,285,804
Held at DTC 2,157,685,216 08/29/2023 >65,655,412
YTD/DTC >599,360,305
@ Webster2000 to aid in your education I highlighted & underlined a key word of what I actually stated.
Once upon a time Dixon's/TSOI's undisclosed IR/CONsultant was telling some that his good friend from Jersey Joe Pesci was going to fund the Phase 3 trial.
$TSOI $Undisclosed
FBI locations
A. Federal Bureau of Investigation
Newark, NJ · (973) 792-3000
Open 24 hours
https://www.fbi.gov/contact-us/field-offices/newark
B. Federal Bureau-Investigation
Cherry Hill, NJ · (856) 795-9556
C. Federal Bureau of Investigation
Red Bank, NJ · (732) 741-0006
Open · Closes 8?PM
FBI Las Vegas
Federal Bureau of Investigation (.gov)
https://www.fbi.gov › contact-us › field-offices › lasve...
FBI Las Vegas. You can report suspicious activities and crime by contacting us 24/7 at (702) 385-1281 or tips.fbi.gov.
Once upon a time Dixon's/TSOI's undisclosed IR/CONsultant was telling some that his good friend from Jersey Joe Pesci was going to fund the Phase 3 trial. That was some funny BS as he had tried to use that line on other tickers as well in the past. Two of Idaho's most valuable crops are potatoes @ #2 w/ $1B while corn is @ #5 w/ $148.7m #Idaho #SweetCorn ranks 1st in U.S. in yield per acre. #Fertilizer or #Organic
.00123 5,000,000 avg 15:02:41